Effective Interferon Lambda Treatment Regimen To Control Lethal MERS-CoV Infection in Mice
- 8 June 2022
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 96 (11) , e0036422
Abstract
Effective antiviral agents are urgently required to prevent and treat individuals infected with SARS-CoV-2 and other emerging viral infections. The COVID-19 pandemic has catapulted our efforts to identify, develop, and evaluate several antiviral agents.Keywords
Funding Information
- HHS | National Institutes of Health (RO1 AI129269)
- HHS | National Institutes of Health (AG060222)
- HHS | National Institutes of Health (P01 AI060699)
This publication has 77 references indexed in Scilit:
- Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic PotentialmBio, 2013
- USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α ResponsePLOS ONE, 2011
- Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivoHepatology, 2011
- Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis CJournal of Interferon & Cytokine Research, 2010
- Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral InfectionsJournal of Virology, 2010
- Human interferon-λ3 is a potent member of the type III interferon familyGenes & Immunity, 2008
- Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic VirusesPLOS Pathogens, 2008
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In VivoPLOS Pathogens, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Coronavirus Infection in Acute Lower Respiratory Tract Disease of InfantsThe Journal of Infectious Diseases, 1974